Abstract:
ObjectiveTo investigate the expression and clinicopathological significance of MAP4K4 (mitogen-activated protein kinase kinase kinase kinase 4, MAP4K4) in hepatocellular carcinoma. Methods We detected the expression of MAP4K4 protein in 400 paired samples of HCC and adjacent tissues through tissue microassay which constructed by 400 paraffin embedded blocks of hepatocellular carcinoma and analyzed the expression level of MAP4K4 protein in different clinicopathological parameters. Results The expression of MAP4K4 was uniformly negative or weakly positive in normal, hepatitis and cirrhosis tissue. There was no positive staining of MAP4K4 in surrounding connective tissue, blood vessel and biliary ducts. Positive staining could be observed in germinal center of Kupffer cells and lympholeukocyte. Compared to the corresponding adjacent tissues, the expression of MAP4K4 was obviously overexpressed in dysplasia nodule cells than that in normal, hepatitis and cirrhosis cells.The expression of MAP4K4 in hepatocellular carcinoma which increased significantly was heterogeneity with the number of overexpressed sample 194(48.5%) and the focus positive or negative 206(51.5%). The positive rate of MAP4K4 in HBsAg carriers was 51.5%(157/305), significantly higher than those in control group at 38.8% (37/95)(P= 0.033). The positive rate of MAP4K4 in tumor diameter≤2 cm was 31.6%(18/57), notably lower than tumor diameter > 2 cm, which was 51.3%(176/343) (P= 0.006). The expression of MAP4K4 was significantly different among different histological grading(P<0.001). The positive rate of MAP4K4 in metastasis was 55.5%(152/274), which was higher than non-metastasis at 33.3%(42/126)(P=0.002). No significant difference was found in the expression of MAP4K4 with different age, serum AFP concentration, degree of liver cirrhosis and capsular infiltration. ConclusionMAP4K4 is generally highly expressed in hepatocellular carcinoma, which may has a certain relationship with HBV infection state, tumor size, histological grade and metastasis status.